News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Specialty:
Multispecialty
Allergy & Immunology
Anesthesiology
Business of Medicine
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Medical Students
Nurses
Pharmacists
Residents
Today on Medscape
Edition:
ENGLISH
DEUTSCH
ESPAÑOL
FRANÇAIS
PORTUGUÊS
Log In
Sign Up It's Free!
Edition:
ENGLISH
DEUTSCH
ESPAÑOL
FRANÇAIS
PORTUGUÊS
Register
Log In
No Results
No Results
Friday, April 19, 2019
News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
close
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit.
Log out
Cancel
Antiretroviral Therapy News
Thousands Feared at Risk After Mexico Reforms HIV+ Regime
Reuters Health Information
, April 18, 2019
New Antibody May Suppress HIV for Up to 16 Weeks Without ART
A novel antibody monotherapy may maintain human immunodeficiency virus (HIV) suppression for up to 16 weeks, newly published data suggest.
Medscape Medical News
, April 17, 2019
Bacterial STIs Increase Among PrEP Users
Medscape Medical News
, April 10, 2019
CROI 2019
Monthly Shots for HIV Within Reach
Medscape Medical News
, March 19, 2019
Most New HIV Cases Stem From People Undiagnosed or Untreated
Medscape Medical News
, March 19, 2019
CROI 2019
'Grappling' With the Value of Descovy for HIV PrEP
Medscape Medical News
, March 7, 2019
More
Antiretroviral Therapy Perspective
CROI 2019
Read clinically focused news coverage of key developments from CROI 2019
Medscape HIV/AIDS
, February 25, 2019
Two- vs Three-Drug Initial Therapy for HIV
Dr Paul Sax describes the potential clinical implications of the GEMINI studies.
Medscape HIV/AIDS
, November 26, 2018
A Precaution About PrEP in HIV Prevention
Medscape HIV/AIDS
, November 12, 2018
Preventing HPV in Patients With HIV: New Guidelines
Medscape HIV/AIDS
, October 26, 2018
HIV 2018
Medscape HIV/AIDS
, October 18, 2018
What Doravirine Offers Patients With HIV
Medscape HIV/AIDS
, September 13, 2018
More
Antiretroviral Therapy Journal Articles
Clinical Trials of ART Interruption in HIV-Infected People
AIDS
, April 19, 2019
Continuum of Care Among HIV/HCV-Coinfection Individuals
HIV Medicine
, April 18, 2019
Changing ART in Pregnancy and Impact on Viral Suppression
JAIDS: Journal of Acquired Immune Deficiency Syndromes
, April 12, 2019
HIV Transmission Along the Continuum of Care
Morbidity & Mortality Weekly Report
, April 12, 2019
HIV Coinfection Among Persons Diagnosed With Hepatitis B
HIV Medicine
, April 11, 2019
More
Medscape Drugs & Diseases: Antiretroviral Therapy
Antiretroviral Therapy for HIV Infection
Cutaneous Manifestations of HIV Disease
HIV Disease
HIV in Pregnancy
Pediatric HIV Infection
Medscape Education: Antiretroviral Therapy
